Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677

Clinical trial NCT00694902 · COMPLETED

Trial details

NCT number: NCT00694902
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2008-05-26
Primary completion: 2008-09-23
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.